ConductScience.org, home

Paper1100221

Clinical comparison of the nitrosoureas.

Wasserman TH and 2 others. Cancer, 1975. Cited by 131 papers, by iCite.

Cite this record

ConductScience Library. Clinical comparison of the nitrosoureas. Papers, record 1100221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1100221

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical comparison of the nitrosoureas.
PubMed
Journal
Cancer
PubMed
Year
1975
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
131
iCite
Relative citation ratio, by iCite
6.16
iCite
Revised in PubMed
2019-06-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wasserman THT H
2Slavik MM
3Carter SKS K

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Nitrosourea CompoundsMajor topic
Animals
Brain Neoplasms
Breast Neoplasms
Carmustine
Chemical Phenomena
Chemistry
Colonic Neoplasms
Drug Therapy, Combination
Hodgkin Disease
Humans
Lomustine
Lung Neoplasms
Lymphoma
Melanoma
Methylnitrosourea
Mice
Neoplasms, Experimental
Rectal Neoplasms

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.

PMIDTitleJournalYearIn PapersSource
18155673Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth.Free Radic Biol Med2008https://conductscience.org/library/papers/18155673PubMed
8699236Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.J Neurooncol1996https://conductscience.org/library/papers/8699236PubMed
7002528Cancer chemotherapy: new developments and changing concepts.Drugs1980https://conductscience.org/library/papers/7002528PubMed
6678867The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.Invest New Drugs1983https://conductscience.org/library/papers/6678867PubMed
6585127Treatment of malignant brain tumours with ACNU and phenobarbital: continuous infusion of ACNU into internal carotid artery and systemic administration of phenobarbital.Acta Neurochir (Wien)1984https://conductscience.org/library/papers/6585127PubMed
6379509Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas.Neurosurg Rev1984https://conductscience.org/library/papers/6379509PubMed
6357517CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6357517PubMed
6249513Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6249513PubMed
6182702Palliative and adjunctive measures in rectal cancer.World J Surg1982https://conductscience.org/library/papers/6182702PubMed
4066223Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.Invest New Drugs1985https://conductscience.org/library/papers/4066223PubMed
2931097DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.Br J Cancer1985https://conductscience.org/library/papers/2931097PubMed
2225319Renal effects of S10036 in man.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2225319PubMed
1742855Positive phase II study in the treatment of advanced malignant melanoma with fotemustine.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1742855PubMed
1428724Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model.Invest New Drugs1992https://conductscience.org/library/papers/1428724PubMed
1331343Treatment of malignant gliomas with surgery, intraarterial chemotherapy with ACNU and radiation therapy.J Neurooncol1992https://conductscience.org/library/papers/1331343PubMed
468900
Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
J Cancer Res Clin Oncol1979https://conductscience.org/library/papers/468900PubMed
92860An A,B,C,D of cancer chemotherapy.West J Med1979https://conductscience.org/library/papers/92860PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1100221

GET https://conductscience.org/api/papers/v1/1100221/authors